from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3726/-

LFCtreatmentdescriptionclass of inhibitor

0.488

Amikacinug/mL Amikacintranslation

-0.134

Cap5-10ug/mL Capreomycintranslation

-0.503

Rox10-50 ug/mL Roxithromycintranslation

0.384

SM2-5 ug/mL Streptomycintranslation

0.444

Tet5-10 ug/mL Tetracyclinetranslation

1.198

Rif0.2-5ug/mL Rifampicintranscription

-0.463

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.541

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.304

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.527

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.064

Clofazimine10-13 ug/mL Clofaziminerespiration

0.228

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.519

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.924

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.537

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.032

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.558

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.734

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.521

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.529

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.216

KCN5-20 ug/mL Potassium cyaniderespiration

-0.411

NaN30.2-2 mM Sodium aziderespiration

0.161

Nigericin50 uM Nigericinrespiration

-0.642

TRC10-150 ug/mL Triclosanrespiration

-0.801

TRZ10-25 ug/mL Thioridazinerespiration

-2.455

Valinomycin0.5-10 uM Valinomycinrespiration

0.612

ZnSO42 mM ZnSO4respiration

-0.145

menadione6-10 ug/mL Menadionerespiration

-0.137

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.043

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.101

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.487

NRP_1Non-replicating persistence stage 1dosRassociated

0.507

Amp0.2mg/mL AmpicillincellWall

0.670

Cephalexin20-100 ug/mL CephalexincellWall

0.176

Cerulenin0.32-5 ug/mL CerulenincellWall

0.899

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.824

EMB10-20 ug/mL EthambutolcellWall

0.817

Eta12-40 ug/mL EthionamidecellWall

0.714

INH0.2-0.4 ug/mL IsoniazidcellWall

0.407

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.405

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.108

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.046

BZA0.12 mg/mL BenzamidearomaticAmides

0.309

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.359

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.740

H2O24 mM hydrogen peroxideDNAdamaging

0.193

Levo10 ug/mL LevofloxacinDNAdamaging

0.755

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.518

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.662

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.789

UVUV-irradiationDNAdamaging

-0.622

ARP41-4 ug/mL Antitubercular compound ARP4?

0.466

Antimycin12.5-50 ug/mL Antimycin A?

-0.017

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.174

PA_110-50 ug/mL Antitubercular compound PA-1?

0.258

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.449

PA8240.2-2 ug/mL PA-824?

-0.746

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.363

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.092

Verapamil50 uM Verapamil?

0.202

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.002

methoxatin10-20 ug/mL Methoxatin?